Cosmos Health Inc. (NASDAQ:COSM) Sees Significant Growth in Short Interest

Cosmos Health Inc. (NASDAQ:COSM) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 537,800 shares, an increase of 53.5% from the December 15th total of 350,300 shares. Currently, 2.9% of the company’s stock are short sold. Based on an average daily volume of 219,100 shares, the days-to-cover ratio is currently 2.5 days.

Insiders Place Their Bets

In other news, CEO Grigorios Siokas acquired 257,334 shares of the company’s stock in a transaction on Friday, December 20th. The shares were bought at an average price of $0.58 per share, with a total value of $149,253.72. Following the completion of the acquisition, the chief executive officer now owns 3,774,314 shares in the company, valued at $2,189,102.12. This trade represents a 7.32 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Georgios Terzis bought 85,778 shares of the business’s stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of $0.58 per share, for a total transaction of $49,751.24. Following the transaction, the chief financial officer now directly owns 727,263 shares of the company’s stock, valued at approximately $421,812.54. This represents a 13.37 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 569,278 shares of company stock valued at $348,841. 15.61% of the stock is owned by corporate insiders.

Cosmos Health Stock Performance

NASDAQ COSM traded up $0.02 on Friday, reaching $0.86. The stock had a trading volume of 452,441 shares, compared to its average volume of 464,086. The stock has a market cap of $19.94 million, a P/E ratio of -0.35 and a beta of 5.57. Cosmos Health has a 12-month low of $0.47 and a 12-month high of $1.58. The business’s 50-day moving average price is $0.71 and its 200 day moving average price is $0.91. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.